What Is 10-Hydroxy-2-Decenoic Acid

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 11, 2026

Quick Answer: 10-Hydroxy-2-decenoic acid (10-HDA) is a unique unsaturated fatty acid with molecular formula C10H18O3 found in royal jelly, comprising 0.5-3.5% of its dry weight. Since 2016, the ISO 12824 standard requires a minimum of 1.4 grams per 100 grams of fresh royal jelly. It exhibits multiple biological properties including antibacterial, antioxidative, anti-inflammatory, and immune-modulating effects.

Key Facts

10-HDA comprises 1.0-3.9% of royal jelly by fresh weight and 0.5-3.5% by dry weight
ISO 12824 standard established in 2016 mandates minimum 1.4g per 100g of fresh royal jelly
Chemical formula C10H18O3 with molecular weight of 186.25 grams per mole
Produced by honeybee hypopharyngeal and mandibular glands exclusively
Demonstrates antibacterial, antioxidative, anti-inflammatory, immunomodulatory and antitumor biological activities

Overview

10-Hydroxy-2-decenoic acid (10-HDA), also known as queen bee acid, is a distinctive unsaturated medium-chain fatty acid exclusively produced by honeybees. With the chemical formula C10H18O3 and a molecular weight of 186.25, this compound is the primary bioactive lipid component found in royal jelly, the nutrient-rich secretion produced by the hypopharyngeal and mandibular glands of worker honeybees. Royal jelly serves as the sole diet for queen bee larvae and continues to nourish adult queens throughout their lives.

The concentration of 10-HDA in royal jelly varies considerably, typically ranging from 1.0% to 3.9% by fresh weight, or 0.5% to 3.5% by dry weight, depending on factors such as bee health, geographic location, seasonal variations, and storage conditions. In 2016, the ISO 12824 international standard was established to standardize royal jelly quality, requiring a minimum of 1.4 grams of 10-HDA per 100 grams of fresh royal jelly. This standardization reflects the growing recognition of 10-HDA as a critical quality marker and bioactive compound of significant pharmaceutical and nutraceutical interest.

How It Works

10-HDA exerts its biological effects through multiple mechanisms:

Antibacterial Action: 10-HDA inhibits the growth of various pathogenic bacteria, making it a natural antimicrobial agent with potential therapeutic applications in fighting bacterial infections.
Antioxidative Properties: As an unsaturated fatty acid with a terminal hydroxyl group, 10-HDA neutralizes harmful free radicals and reduces oxidative stress in cells, protecting cellular components from damage.
Anti-Inflammatory Effects: The compound modulates inflammatory pathways, reducing the production of pro-inflammatory cytokines and helping to alleviate chronic inflammatory conditions.
Immune Modulation: 10-HDA enhances immune system function by activating immune cells and promoting the production of antibodies, strengthening the body's defense mechanisms.
Cellular Differentiation: Research demonstrates that 10-HDA promotes neurogenesis in neural stem and progenitor cells, suggesting potential applications in neurodegenerative disease treatment and cognitive enhancement.
Osteoclast Inhibition: The compound potently inhibits osteoclastogenesis, the formation of bone-resorbing cells, which has implications for bone health and osteoporosis prevention.

Key Comparisons

Characteristic	10-HDA	Other Royal Jelly Components
Primary Source	Honeybee hypopharyngeal glands	Mixed bee secretions and pollen
Concentration in Royal Jelly	1.0-3.9% fresh weight	Varies (proteins 10-13%, carbohydrates 10-16%)
Chemical Classification	Unsaturated fatty acid (C10)	Diverse (proteins, polysaccharides, vitamins)
Stability Standard	ISO 12824 minimum 1.4g/100g (since 2016)	Less standardized internationally
Bioactivity Focus	Antimicrobial, anti-inflammatory, neurogenic	General nutritional and immunomodulatory

Why It Matters

Pharmaceutical Development: 10-HDA's demonstrated antibacterial, antitumor, and anti-inflammatory properties make it a valuable candidate for developing new medications to treat infections, cancer, and inflammatory diseases.
Longevity Research: Studies have shown that 10-HDA extends lifespan in laboratory organisms through dietary restriction and target of rapamycin (mTOR) signaling pathways, suggesting potential anti-aging applications.
Quality Control: The ISO 12824 standard established in 2016 uses 10-HDA content as a key marker for royal jelly authenticity and quality, protecting consumers from adulterated products.
Nutraceutical Applications: As a bioavailable compound with multiple health-promoting properties, 10-HDA is increasingly incorporated into dietary supplements and functional foods targeting immune health, inflammation reduction, and cognitive support.
Biotechnology Innovation: Recent advances in synthetic biology have enabled efficient biosynthesis of 10-HDA using recombinant enzymes and whole-cell catalytic systems, reducing dependence on natural extraction and enabling sustainable large-scale production.

The significance of 10-HDA extends beyond traditional apitherapy into modern science and medicine. As research continues to uncover its mechanisms of action and therapeutic potential, 10-HDA represents a bridge between traditional bee product medicine and contemporary pharmaceutical science. The compound's unique bioavailability, combined with its multiple biological activities, positions it as a promising therapeutic agent for future medical applications targeting inflammation, oxidative stress, microbial infections, and age-related degenerative conditions.